Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

17 December 2021: Animal Study

Galangin Enhances Anticancer Efficacy of 5-Fluorouracil in Esophageal Cancer Cells and Xenografts Through NLR Family Pyrin Domain Containing 3 (NLRP3) Downregulation

Cong Zhang 1ABF* , Cui-Lian Luo 1BCD* , Guan-Sheng Shang 1DE , De-Xiong Jiang 1BF , Qi Song 2AG*

DOI: 10.12659/MSM.931630

Med Sci Monit 2021; 27:e931630

Figure 5 Galangin modulated cell death through the NLRP3 inflammasome but not the AKT pathway in human esophageal cancer cells after fluorouracil (5-FU) treatment. Total cell extracts were obtained and subjected to western blot analysis, which included anti-AKT, phospho-AKT, NLRP3, IL-1β, cleaved PARP (PARP1), and β-actin. The Eca109 and OE19 cells were also treated with DMSO (control), 5-FU, 5-FU+galangin, and 5-FU+galangin+nigericin solution. AKT – protein kinase B; DMSO – dimethyl sulfoxide; IL-1β – interleukin 1β; NLRP3 – NLR family pyrin domain containing 3; PARP – poly (ADP-ribose) polymerase.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750